Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnoud J Templeton

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Nature Reviews. Clinical Oncology|April 11, 2020
Informative censoring - a neglected cause of bias in oncology trialsArnoud J Templeton, Eitan Amir, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Informing Patients About Expected Outcomes: The Efficacy-Effectiveness GapArnoud J Templeton, Christopher M Booth, Ian F Tannock
Molecular Cancer|August 17, 2017
Neutrophils in cancer: prognostic role and therapeutic strategiesAlberto Ocana, Cristina Nieto-Jiménez, Atanasio Pandiella, et al.
Clinical Genitourinary Cancer|January 21, 2018
Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective StudiesPooja Ghatalia, Gregory R Pond, Arnoud J Templeton, et al.
Plos One|May 30, 2020
Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancerTill Wallrabenstein, Jessica Del Rio, Arnoud J Templeton, et al.
Complementary Medicine Research|February 12, 2025
ER+ HER2- Invasive Breast Cancer: Tumor Remission following Viscum Album Extract/Influenza Vaccine Treatment - A Report of 2 CasesSaphira Kaesbach, Alexander Hintze, Swantje Engelbrecht, et al.
Current Oncology Reports|February 26, 2013
Benefit and harms of new anti-cancer drugsFrancisco E Vera-Badillo, Mustafa Al-Mubarak, Arnoud J Templeton, et al.
Plos One|December 3, 2025
What do future physicians think of traditional, complementary, and integrative medicine (TCIM)? Fifteen years after the inclusion of TCIM in the Swiss constitutionIlana Berlowitz, Helena Adler, Daniel Gallego Perez, et al.
Oncology|November 20, 2017
Reporting of Randomized Trials in Common Cancers in the Lay MediaDomen Ribnikar, Hadar Goldvaser, Alberto Ocana, et al.
Experimental and Molecular Pathology|May 17, 2017
Prognostic role of telomere length in malignancies: A meta-analysis and meta-regressionRoman Adam, Laura Díez-González, Alberto Ocaña, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Nature Reviews. Clinical Oncology|April 11, 2020
Informative censoring - a neglected cause of bias in oncology trialsArnoud J Templeton, Eitan Amir, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Informing Patients About Expected Outcomes: The Efficacy-Effectiveness GapArnoud J Templeton, Christopher M Booth, Ian F Tannock
Molecular Cancer|August 17, 2017
Neutrophils in cancer: prognostic role and therapeutic strategiesAlberto Ocana, Cristina Nieto-Jiménez, Atanasio Pandiella, et al.
Clinical Genitourinary Cancer|January 21, 2018
Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective StudiesPooja Ghatalia, Gregory R Pond, Arnoud J Templeton, et al.
Plos One|May 30, 2020
Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancerTill Wallrabenstein, Jessica Del Rio, Arnoud J Templeton, et al.
Complementary Medicine Research|February 12, 2025
ER+ HER2- Invasive Breast Cancer: Tumor Remission following Viscum Album Extract/Influenza Vaccine Treatment - A Report of 2 CasesSaphira Kaesbach, Alexander Hintze, Swantje Engelbrecht, et al.
Current Oncology Reports|February 26, 2013
Benefit and harms of new anti-cancer drugsFrancisco E Vera-Badillo, Mustafa Al-Mubarak, Arnoud J Templeton, et al.
Plos One|December 3, 2025
What do future physicians think of traditional, complementary, and integrative medicine (TCIM)? Fifteen years after the inclusion of TCIM in the Swiss constitutionIlana Berlowitz, Helena Adler, Daniel Gallego Perez, et al.
Oncology|November 20, 2017
Reporting of Randomized Trials in Common Cancers in the Lay MediaDomen Ribnikar, Hadar Goldvaser, Alberto Ocana, et al.
Experimental and Molecular Pathology|May 17, 2017
Prognostic role of telomere length in malignancies: A meta-analysis and meta-regressionRoman Adam, Laura Díez-González, Alberto Ocaña, et al.
Pageof 10